International Dateline

International Dateline

Statins for the Prevention of Acute Pancreatitis

  • The American Journal of Gastroenterology 112, 17651767 (2017)
  • doi:10.1038/ajg.2017.396
  • Download Citation
Published online:
  • Subscribe to The American Journal of Gastroenterology for full access:

    $870

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

References

  1. 1.

    . The origin of the statins. 2004. Atheroscler Suppl 2004;5:125–130.

  2. 2.

    , , et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 2016;37:2999–3058.

  3. 3.

    , . Pleiotropic effects of statins.—Basic research and clinical perspectives. Circ J 2010;74:818–826.

  4. 4.

    , , . Mechanisms for the anti-inflammatory effects of statins. Curr Opin Lipidol 2011;22:165–170.

  5. 5.

    , , et al. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol 2007;5:648–661 quiz 4.

  6. 6.

    , , et al. Statins and the risk of acute pancreatitis: a population-based case-control study. Aliment Pharmacol Ther 2006;23:185–190.

  7. 7.

    , , et al. Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA 2012;308:804–811.

  8. 8.

    , , et al. Prior statin therapy is associated with milder course and better outcome in acute pancreatitis—a cohort study. Pancreatology 2013;13:196–200.

  9. 9.

    , , . Simvastatin is associated with reduced risk of acute pancreatitis: findings from a regional integrated healthcare system. Gut 2015;64:133–138.

  10. 10.

    , , et al. Treatment with pravastatin attenuates progression of chronic pancreatitis in rat. Lab Invest 2011;91:872–884.

  11. 11.

    , , , et al. Inhibition of pancreatic stellate cell activation by the hydroxymethylglutaryl coenzyme A reductase inhibitor lovastatin. Biochem Pharmacol 2003;65:1295–1303.

  12. 12.

    , , et al. The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, lovastatin (statin) ameliorates CCK-induced acute pancreatitis in rats. Biol Pharm Bull 2005;28:1394–1397.

  13. 13.

    , , et al. Statin pretreatment in experimental acute pancreatitis. JOP 2008;9:431–439.

  14. 14.

    , , . Antioxidant activity of simvastatin prevents L-arginine-induced acute toxicity of pancreas. Int J Physiol Pathophysiol Pharmacol 2013;5:102–108.

  15. 15.

    , , et al. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline—updated June 2014. Endoscopy 2014;46:799–815.

  16. 16.

    , , et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007;102:1781–1788.

  17. 17.

    , , et al. Statins chronic use is associated to decreased post-ERCP acute pancreatitis incidence. Pancreatology 2017;17 (3 Supplement): 2.

  18. 18.

    , , et al. Rectal indomethacin does not prevent post-ERCP pancreatitis in consecutive patients. Gastroenterology 2016;150:911–917 quiz e19.

  19. 19.

    , , et al. The efficacy and safety of high-dose statins in acute phase of ischemic stroke and transient ischemic attack: a systematic review. Intern Emerg Med 2017;12:679–687.

  20. 20.

    , , . Natural history following the first attack of acute pancreatitis. Am J Gastroenterol 2012;107:1096–1103.

  21. 21.

    SIMBA trial: Simvastatin in the Prevention of Recurrent Acute Pancreatitis, a Triple Blind Randomized Controlled Trial EU Clinical Trials Register2016 [updated 08-05-2016. Available from .

  22. 22.

    , , , . Use of simvastatin and risk of acute pancreatitis: a nationwide case-control study in Taiwan. J Clin Pharmacol 2017;57:918–23.

  23. 23.

    , , . Atorvastatin use associated with acute pancreatitis: a case-control study in Taiwan. Medicine (Baltimore) 2016;95:e2545.

  24. 24.

    , , et al. Use of statins and the risk of acute pancreatitis: a population-based case-control study. Pharmacoepidemiol Drug Saf 2015;24:1085–92.

  25. 25.

    , , et al. Prior statin use and the outcomes in patients with first-attack acute pancreatitis: a retrospective cohort study. Eur J Intern Med 2015;26:425–8.

  26. 26.

    , , . Rosuvastatin and risk of acute pancreatitis in a population-based case-control study. Int J Cardiol 2015;187:417–20.

  27. 27.

    , , et al. Statin use in patients with acute pancreatitis and symptomatic gallstone disease. Pancreas 2014;43:638–41.

Download references

Author information

Affiliations

  1. Gastroenterology Department, Alicante University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain

    • Enrique de-Madaria

Authors

  1. Search for Enrique de-Madaria in:

Competing interests

Guarantor of the article: Enrique de-Madaria, MD.

Specific author contributions: Enrique de-Madaria wrote the manuscript.

Financial support: None.

Potential competing interests: None.

Corresponding author

Correspondence to Enrique de-Madaria.